Sitthichai Kanokudom

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong et al. · Vaccines · 2022 · 89 citations · Full text

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian et al. · Human Vaccines & Immunotherapeutics · 2022 · 66 citations · Full text

Immunology, Intermittent Supply Shortages, Vaccine Hesitancy +20

Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination

Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong et al. · The Journal of Infectious Diseases · 2022 · 61 citations

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults

Ritthideach Yorsaeng, Nungruthai Suntronwong, Harit Phowatthanasathian et al. · Vaccine · 2021 · 57 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +6

miR-21 promotes dengue virus serotype 2 replication in HepG2 cells

Sitthichai Kanokudom, Tirayut Vilaivan, Nitwara Wikan et al. · Antiviral Research · 2017 · 54 citations

Viral Replication, Molecular Virology, Pathogenesis +9